CD14 and Behcet disease: The P-selectin increase was significantly lower in the anti-CD14 treated group, FC 7.4 (2.8–12) (p < 0.0001), and the dual treatment group, FC 20 (3.0–37) (p = 0.0009), compared to the BD group, whereas for the coversin group only a trend was observed, FC 57 (25–89) (p = 0.06) (Fig. 5B).